Though we’re nowhere near machines taking over, artificial intelligence has a plethora of applications in healthcare. The oncology space is no exception.
The intersection of artificial intelligence and cancer care is up for discussion at the forthcoming MedCity CONVERGE conference in Philadelphia on July 11-12.
Leslie Weber was inducted in June as chair of the board of directors of the Montgomery County Chamber of Commerce. Weber is director of the Johns Hopkins University Montgomery County Campus and director of government and community affairs for Johns Hopkins in Montgomery County. She long has been involved with the Chamber: She has held leadership positions on the board and received the Chairman’s Award in 2016.
The city has begun testing its hypothesis that real estate costs and other hurdles stood in the way of a booming life science sector by supporting three biotech incubators.
Two of the incubators, which offer young companies an affordable workspace, lab equipment and networking opportunities, have started welcoming tenants. But data on the strategy’s success has been sparse.
The Maryland Technology Enterprise Institute (Mtech) at the University of Maryland, College Park seeks an organized, energetic person to assist with operational functions and related activities for the Entrepreneurship and Innovation Program in the Honors College.
This nationally award-winning program helps to develop the entrepreneurial mindsets, skill sets and resources for first and second-year students.
The position-holder would provide coordination and support for
program operations and administration courses and curriculum student activities and engagement marketing and recruiting development and grants
Johns Hopkins University is again the top NIH grant recipient in Greater Baltimore in 2017, with a total grant value of $651.8 million last year.
The university also led all U.S. universities in research and development expenditures for the 38th consecutive year in fiscal year 2016, spending $2.4 billion on various research projects.
Two Rockville employers are among the top workplaces in the region, according to The Washington Post’s newest ranking.
There is limited data available on Health Tech investing in general and even less related to early stage investing in the sector. IPHA set out to fill that gap by analyzing quarterly health tech investing data between 2010 through Q1 2018. We track both total investment dollars and deals completed over the period with additional analysis of the five quarters leading up to March 31, 2018. There is an unmistakeable trend reversal that started in Q1 2017 that is significant for both health tech entrepreneurs and investors.
Women and men almost equally shared all positions in the life sciences world, but women are not advancing in their biopharma careers at the same pace as men, according to a recent report by the Massachusetts Biotechnology Council and recruiting firm Liftstream. The wide gender gap higher up, though improved in recent years, persists: Women only hold a quarter of all C-suite level jobs, and less than 15% joined the board of directors.
Lupin has announced that it has partnered with Mylan to commercialize Enbrel (Etanercept) biosimilar. Under the terms of the agreement, Lupin will receive an up-front payment of $15mn and potential commercial milestones together with an equal share in net profits of the product. Mylan will commercialize Lupin’s Etanercept biosimilar in Europe, Australia, New Zealand, Latin America, Africa and most markets throughout Asia.
Venture investors poured more than $1 billion into agtech last year, and we are on pace to match or exceed that this year. The convergence of AI, cloud computing, big data and gene editing, with applications from soil to plants, foods to medicines, farm to table are driving investments. Discerning startups and investors will capitalize from the market’s current, numerous opportunities.
